Published in Medicine and Law Weekly, August 3rd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at H. Lee Moffitt Cancer Center & Research Institute.
Report 1: Doctors at H. Lee Moffitt Cancer Center & Research Institute are examining the results of a targeted and sequence-specific therapy meant to improve the effects of chemotherapy in cancer patients via the use of a sensitizing agent prior to chemotherapy treatment.
The clinical and translational Phase I trial describing this therapy in patients with advanced solid tumor...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.